Sara Veronica Usai
Overview
Explore the profile of Sara Veronica Usai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martelli M, Ceriani L, Ciccone G, Ricardi U, Kriachok I, Botto B, et al.
J Clin Oncol
. 2024 Aug;
42(34):4071-4083.
PMID: 39159403
Purpose: The role of consolidation radiotherapy in patients with primary mediastinal B-cell lymphoma (PMBCL) is controversial. Methods: The IELSG37 trial, a randomized noninferiority study, aimed to assess whether irradiation can...
2.
Clerico M, Ferrero S, Alessandria B, Zaccaria G, Genuardi E, Ragaini S, et al.
Sci Rep
. 2024 Jul;
14(1):16946.
PMID: 39043871
In the frontline high-dose phase 3 FIL-MCL0208 trial (NCT02354313), 8% of enrolled mantle cell lymphoma (MCL) patients could not be randomised to receive lenalidomide (LEN) maintenance vs observation after autologous...
3.
Guerra L, Chauvie S, Fallanca F, Bergesio F, Marcheselli L, Durmo R, et al.
Eur J Nucl Med Mol Imaging
. 2024 May;
51(11):3311-3321.
PMID: 38795120
Purpose: To evaluate the reliability of the Deauville score (DS) in therapy response assessment and to define the prognostic value of the metabolic response of end of induction (EOI) [F]FDG...
4.
Arcari A, Rigacci L, Tucci A, Puccini B, Usai S, Cavallo F, et al.
Blood Adv
. 2023 Jun;
7(15):4160-4169.
PMID: 37276080
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the most commonly used regimen for the upfront treatment of diffuse large B-cell lymphoma (DLBCL). However, it is associated with cardiotoxicity, especially...
5.
Arcari A, Tabanelli V, Merli F, Marcheselli L, Merli M, Balzarotti M, et al.
Br J Haematol
. 2023 Feb;
201(4):653-662.
PMID: 36733229
Up to 10%-15% of diffuse large B-cell lymphoma (DLBCL) are related to hepatitis C virus (HCV) infection, in particular in elderly patients. The Fondazione Italiana Linfomi has recently published a...
6.
Chiappella A, Dodero A, Evangelista A, Re A, Orsucci L, Usai S, et al.
Leukemia
. 2023 Jan;
37(2):433-440.
PMID: 36653509
The standard treatment for young patients with untreated PTCLs is based on anthracycline containing-regimens followed by high-dose-chemotherapy and stem-cell-transplantation (HDT + SCT), but only 40% of them can be cured....
7.
Cencini E, Tucci A, Puccini B, Cavallo F, Luminari S, Usai S, et al.
Hematol Oncol
. 2022 Sep;
41(1):78-87.
PMID: 36177902
The Elderly Prognostic Index (EPI) is based on the integration of a simplified geriatric assessment, hemoglobin levels and International Prognostic Index and has been validated to predict overall survival in...
8.
Merli F, Luminari S, Tucci A, Arcari A, Rigacci L, Hawkes E, et al.
J Clin Oncol
. 2021 Feb;
39(11):1214-1222.
PMID: 33577377
Purpose: To prospectively validate the use of a simplified geriatric assessment (sGA) at diagnosis and to integrate it into a prognostic score for older patients with diffuse large B-cell lymphoma...